Human anti-human cd3 binding molecules
CA 2523716 C · Owner: Kohleisen, Birgit · Inventors: Raum, Tobias; Itin, Christian; Kufer, Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a method for the preparation of a human binding molecule, fragment or derivative thereof which specifically binds to the human CD3 complex. Furthermore, the invention provides a human binding molecules specifically binding to the human CD3 complex and means comprising said human binding molecules.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 26, 2004 and granted November 25, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 26, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 26, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.